Intellia Therapeutics, Inc. (NTLA) News & Info.

#ThinkSabio Latest News

Intellia Therapeutics to Present Data from the Phase 2 Study of NTLA-2002 for the Treatment of Hereditary Angioedema (HAE) at the 2024 ACAAI Annual Scientific Meeting